
Cardiac muscle electrophysiology, calcium dynamics and contractile regulation: Molecules to Heart.

Cellular and molecular mechanisms of cardiac plasticity and disease.

Central neuroplasticity in cardiovascular regulation.

Cellular and molecular mechanisms of heart disease and biophysics of the cardiac muscle excitation, contraction coupling.

Potassium channels in ischemic stroke and neuroinflammation.

Functional roles of different isoforms of cardiac calcium channels using combined techniques of transgenic mouse models, gene silencing and patch-clamp recordings.

Computational approaches to reveal mechanisms of excitability in the heart and brain.

Functional genomics of nervous system development.

Virulence determinants of fungal pathogenesis.

Cellular mechanisms of complex cardiac arrhythmia diseases, such as heart failure and atrial fibrillation.

Molecular basis of synaptic plasticity and the role of signaling complexes.

Unconventional cyclin function during cellular growth, differentiation and stress responses.
Chemokine receptors as therapeutic targets both for autoimmunity and for the treatment of malaria.

Dynamics and stability of the cardiac control system.

Understanding the role of protein localization and post-translational modification of heat shock proteins (HSPs) and the estrogen receptor in cardiovascular disease.

Mechanisms of excitation - contraction and excitation - transcription coupling in arterial myocytes.

Mechanisms of cardiac arrhythmias; cardiovascular molecular imaging.

Cellular neurophysiology of ion channels; neurological therapeutics, with an emphasis on antiepileptic drugs and other epilepsy treatment approaches; treatment of traumatic brain injury and post-traumatic epilepsy.

Mathematical modeling of action potential and calcium cycling. Nonlinear dynamics of cardiac phenomena including alternans, early and delayed afterdepolarizations, Ca sparks, Ca waves.

Engineering zinc finger DNA-binding proteins for diagnostics and gene therapy.

Potassium channel modulators for the treatment of autoimmune and cardiovascular disease.

Neurohormonal regulation of GPCR signaling in heart failure and Alzheimer's diseases.